The NFκB Antagonist CDGSH Iron-Sulfur Domain 2 Is a Promising Target for the Treatment of Neurodegenerative Diseases

Abstract

Proinflammatory response and mitochondrial dysfunction are related to the pathogenesis of neurodegenerative diseases (NDs). Nuclear factor κB (NFκB) activation has been shown to exaggerate proinflammation and mitochondrial dysfunction, which underlies NDs. CDGSH iron-sulfur domain 2 (CISD2) has been shown to be associated with peroxisome proliferator-activated receptor-β (PPAR-β) to compete for NFκB and antagonize the two aforementioned NFκB-provoked pathogeneses. Therefore, CISD2-based strategies hold promise in the treatment of NDs. CISD2 protein belongs to the human NEET protein family and is encoded by the CISD2 gene (located at 4q24 in humans). In CISD2, the [2Fe-2S] cluster, through coordinates of 3-cysteine-1-histidine on the CDGSH domain, acts as a homeostasis regulator under environmental stress through the transfer of electrons or iron-sulfur clusters. Here, we have summarized the features of CISD2 in genetics and clinics, briefly outlined the role of CISD2 as a key physiological regulator, and presented modalities to increase CISD2 activity, including biomedical engineering or pharmacological management. Strategies to increase CISD2 activity can be beneficial for the prevention of inflammation and mitochondrial dysfunction, and thus, they can be applied in the management of NDs.

Repaglinide Elicits a Neuroprotective Effect in Rotenone-Induced Parkinson’s Disease in Rats: Emphasis on Targeting the DREAM-ER Stress BiP/ATF6/CHOP Trajectory and Activation of Mitophagy

“…Recently, our group and others have uncovered multiple therapeutic targets for the treatment of neurodegenerative diseases. ,,, Notably, a rising number of studies suggest that focusing on ER stress in treating neurodegeneration is a feasible therapeutic approach to PD. ,, An earlier work done on IRE1α knockout PD mice model highlighted the chief role of mesencephalic astrocyte-derived neurotrophic factor in mitigating ER stress. By directly binding to IRE1α, it augments UPR and as a result preserves the count of viable dopamine neurons .…”

Multi‐omics analysis reveals that ferroptosis‐related gene CISD2 is a prognostic biomarker of head and neck squamous cell carcinoma

“…Previous studies have proved its significant role in the Wnt, AKT/m-TOR, and CISD2/PPAR-β/NF-κB signaling pathways. 22,45,46 As a potential and attractive biomarker, inhibition of CISD2 might serve as a potential therapeutic strategy for cancer therapy. The upregulation of CISD2 was observed in HNSCC instead of normal tissues (such as oral epithelium, cervical lymph nodes, etc.).…”

Freshwater Clam Extract Mitigates Neuroinflammation and Amplifies Neurotrophic Activity of Glia: Insights from In Vitro Model of Neurodegenerative Pathomechanism

“…With excessive immunocompetence during aging or abnormal protein folding/aggregation caused by environmental and genetic factors, microglia activation remains the initial step towards the neuroinflammatory response. Stimulated M1phase microglia have been shown to directly activate astrocytes and reciprocally modulate the innate immune defenses of the CNS (via microglia-astrocyte crosstalk) [68]. Inflamed glial cells further exacerbate the neurodegenerative process by producing and releasing neurotoxins such as NO [44], which is involved in the degeneration of oligodendrocytes in multiple sclerosis and in the death of neurons in AD and PD [45].…”